EU Says AstraZeneca Contract Should Be Published

The transcript discusses the European Union's export restrictions on COVID-19 vaccines, focusing on the need for companies to obtain authorization before shipping vaccines outside the EU. It highlights the EU's unusual public stance against AstraZeneca and the challenges faced in ensuring vaccine distribution aligns with financial contributions. The EU's PR difficulties and the insistence on transparency through the AstraZeneca contract are also covered.

What concerns do European officials have regarding vaccine distribution?

What commitment did the European Union make regarding the AstraZeneca contract?